FDA Approved: MITIGO — Supplemental Application (Piramal Critical Care, Inc.)

View source ↗

Summary

FDA approved a supplemental submission for MITIGO (morphine sulfate) by Piramal Critical Care, Inc., approving changes to an existing morphine sulfate product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain
• Pain
• Postoperative Pain

Drugs mentioned

• MITIGO (MORPHINE SULFATE)

Snippet

SUPPL AP for MITIGO (MORPHINE SULFATE)